- $29.03m
- $18.42m
- $101.43m
Brief: TSR Reports Results For The Second Quarter Ended November 30, 2023
Brief: TSR Board Of Directors Announces Exploration Of Strategic Alternatives
Brief: TSR Reports Q3 EPS Of $0.04
Brief: Tsr Inc Reports Results For Q2 Ended November 30, 2022
Brief: Tsr Inc. Reports Results For The First Quarter Ended Aug 31, 2022
Brief: Tsr Inc - Authorized A Stock Repurchase Program Of Up To $500,000 Of Company's Outstanding Common Stock
Brief: TSR Reports Revenue For Fourth Quarter And Fiscal Year Ended May 31, 2022
Brief: TSR Inc Qtrly Revenue Up 42.1% To $24.4 Mln
TSR Inc gains on Q3 revenue jump, smaller loss
TSR jumps above two-month high on strong Q2 revenue
Brief: TSR Reports Q2 EPS Of $0.12
Brief: TSR Inc Posts Q1 Earnings Per Share $3.18
Brief: TSR Files For Offering Of Common Stock Of Up To $5 Mln
Brief: TSR Inc. Settles Litigation With Former CEO Christopher Hughes
U.S. STOCKS ON THE MOVE-Meten, nCino, American Eagle, pharma stocks
NASDAQ RESUMED AT 12:03 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:59 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:45 AM
Brief: TSR Inc Reports Record Revenues For Fourth Quarter